Literature DB >> 11287424

Aggretin, a heterodimeric C-type lectin from Calloselasma rhodostoma (Malayan pit viper), stimulates platelets by binding to α2β1 integrin and glycoprotein Ib, activating Syk and phospholipase Cγ 2, but does not involve the glycoprotein VI/Fc receptor γ chain collagen receptor.

A Navdaev1, J M Clemetson, J Polgar, B E Kehrel, M Glauner, E Magnenat, T N Wells, K J Clemetson.   

Abstract

Aggretin, a potent platelet activator, was isolated from Calloselasma rhodostoma venom, and 30-amino acid N-terminal sequences of both subunits were determined. Aggretin belongs to the heterodimeric snake C-type lectin family and is thought to activate platelets by binding to platelet glycoprotein alpha(2)beta(1). We now show that binding to glycoprotein (GP) Ib is also required. Aggretin-induced platelet activation was inhibited by a monoclonal antibody to GPIb as well as by antibodies to alpha(2)beta(1). Binding of both of these platelet receptors to aggretin was confirmed by affinity chromatography. No binding of other major platelet membrane glycoproteins, in particular GPVI, to aggretin was detected. Aggretin also activates platelets from Fc receptor gamma chain (Fcgamma)-deficient mice to a greater extent than those from normal control mice, showing that it does not use the GPVI/Fcgamma pathway. Platelets from Fcgamma-deficient mice expressed fibrinogen receptors normally in response to collagen, although they did not aggregate, indicating that these platelets may partly compensate via other receptors including alpha(2)beta(1) or GPIb for the lack of the Fcgamma pathway. Signaling by aggretin involves a dose-dependent lag phase followed by rapid tyrosine phosphorylation of a number of proteins. Among these are p72(SYK), p125(FAK), and PLCgamma2, whereas, in comparison with collagen and convulxin, the Fcgamma subunit neither is phosphorylated nor coprecipitates with p72(SYK). This supports an independent, GPIb- and integrin-based pathway for activation of p72(SYK) not involving the Fcgamma receptor.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11287424     DOI: 10.1074/jbc.M101585200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

1.  Cobalt hematoporphyrin inhibits CLEC-2-podoplanin interaction, tumor metastasis, and arterial/venous thrombosis in mice.

Authors:  Nagaharu Tsukiji; Makoto Osada; Tomoyuki Sasaki; Toshiaki Shirai; Kaneo Satoh; Osamu Inoue; Norihiko Umetani; Chihiro Mochizuki; Tamio Saito; Soichi Kojima; Hideyuki Shinmori; Yukio Ozaki; Katsue Suzuki-Inoue
Journal:  Blood Adv       Date:  2018-09-11

2.  Platelet activation receptor CLEC-2 regulates blood/lymphatic vessel separation by inhibiting proliferation, migration, and tube formation of lymphatic endothelial cells.

Authors:  Makoto Osada; Osamu Inoue; Guo Ding; Toshiaki Shirai; Hirotake Ichise; Kazuyoshi Hirayama; Katsuhiro Takano; Yutaka Yatomi; Masanori Hirashima; Hideki Fujii; Katsue Suzuki-Inoue; Yukio Ozaki
Journal:  J Biol Chem       Date:  2012-05-03       Impact factor: 5.157

3.  Genetic variation responsible for mouse strain differences in integrin alpha 2 expression is associated with altered platelet responses to collagen.

Authors:  Tong-Tong Li; Susana Larrucea; Shiloe Souza; Suzanne M Leal; José A López; Edward M Rubin; Bernhard Nieswandt; Paul F Bray
Journal:  Blood       Date:  2004-01-22       Impact factor: 22.113

Review 4.  Why do we study animal toxins?

Authors:  Yun Zhang
Journal:  Dongwuxue Yanjiu       Date:  2015-07-18

5.  The C-type lectin receptors CLEC-2 and Dectin-1, but not DC-SIGN, signal via a novel YXXL-dependent signaling cascade.

Authors:  Gemma L J Fuller; Jennifer A E Williams; Michael G Tomlinson; Johannes A Eble; Sheri L Hanna; Stefan Pöhlmann; Katsue Suzuki-Inoue; Yukio Ozaki; Steve P Watson; Andrew C Pearce
Journal:  J Biol Chem       Date:  2007-03-05       Impact factor: 5.157

6.  In vitro assessment and phase I randomized clinical trial of anfibatide a snake venom derived anti-thrombotic agent targeting human platelet GPIbα.

Authors:  Benjamin Xiaoyi Li; Xiangrong Dai; Xiaohong Ruby Xu; Reheman Adili; Miguel Antonio Dias Neves; Xi Lei; Chuanbin Shen; Guangheng Zhu; Yiming Wang; Hui Zhou; Yan Hou; Tiffany Ni; Yfke Pasman; Zhongqiang Yang; Fang Qian; Yanan Zhao; Yongxiang Gao; Jing Liu; Maikun Teng; Alexandra H Marshall; Eric G Cerenzia; Mandy Lokyee Li; Heyu Ni
Journal:  Sci Rep       Date:  2021-06-03       Impact factor: 4.379

7.  Documentation of a proven Mountain Pitviper (Ovophis monticola) envenomation in Kathmandu, Nepal, with its distribution ranges: implications for prevention and control of pitviper bites in Asia.

Authors:  Deb Prasad Pandey; Budhan Chaudhary; Bhola Ram Shrestha
Journal:  J Venom Res       Date:  2021-01-06

8.  Intact protein mass spectrometry reveals intraspecies variations in venom composition of a local population of Vipera kaznakovi in Northeastern Turkey.

Authors:  Daniel Petras; Benjamin-Florian Hempel; Bayram Göçmen; Mert Karis; Gareth Whiteley; Simon C Wagstaff; Paul Heiss; Nicholas R Casewell; Ayse Nalbantsoy; Roderich D Süssmuth
Journal:  J Proteomics       Date:  2019-02-11       Impact factor: 3.855

9.  Crystallization and X-ray diffraction analysis of human CLEC-2.

Authors:  Aleksandra A Watson; Christopher A O'Callaghan
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2005-11-24

Review 10.  Platelet CLEC-2 and lung development.

Authors:  Katsue Suzuki-Inoue; Nagaharu Tsukiji
Journal:  Res Pract Thromb Haemost       Date:  2020-04-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.